INAUGURAL · NOVEMBER 9–10, 2026 · PHILADELPHIA, PA
AGENT ı C PHARMA S U M M I T

Where life sciences commercial leaders collaborate and prepare for what's next with Agentic AI.

ABOUT THE SUMMIT

From AI adoption to agentic execution.

AI answers. Agentic AI acts. You give an agent an outcome and it charts its own path: picks the tools, runs the steps, delivers the finished work. The moment you stop approving every step and start reviewing the result, your system is agentic.

That shift does not stay in the sandbox. It lands on your data, your MLR workflows, your field teams, and the budget you have to defend. Two days on what worked, what did not, and what comes next.

WHO THIS IS FOR

Senior commercial leaders working on agentic AI.

Built for commercial teams working on:
Marketing and Brand Leadership
Commercial AI and Innovation
Sales and Commercial Operations
Data, Analytics and Insights
Digital and Omnichannel Strategy
Marketing Technology and Platforms
Commercial Excellence
Content and Creative Operations
Customer Engagement and Experience
Patient Services and Experience
Market Access
Agency and Partner Strategy

Technology vendors, solution providers, and agencies serving life sciences commercial are welcome too. If you are building or bringing agentic AI to this audience, you belong here.

Register Today
FOUNDING ADVISORY COUNCIL

Shaped by the leaders living it.

The Founding Advisory Council brings a cross-section of the commercial organization to help set the proper foundation for this timely and important event. Our advisors serve the event by extending their experience, perspective, as well as their networks to ensure that we develop a program agenda that is built by the industry, for the industry.

Vinicius Dantas Alves

Vinícius Dantas Alves

AVP, Global Brand Lead

Kamya Elawadhi

Kamya Elawadhi

Co-Founder & President

Matt Goff

Matt Goff

Executive Director, Competitive Intelligence & Corporate Communications

Cedric Grand-Pierre

Cedric Grand-Pierre

SVP, Customer Engagement Excellence

Shwen Gwee

Shwen Gwee

Head of AI Partnerships

Alice Harmon

Alice Harmon

Director, Omnichannel Analytics & Strategy

Ericka Higgins-Tothe

Ericka Higgins-Tothe

VP, Customer Engagement & Omnichannel

Shaji Kalathil

Shaji Kalathil

VP, Head of Digital, Tech & Analytics

Matt Lasmanis

Matt Lasmanis

SVP, Chief Digital Officer

Shawn O'Hagan

Shawn O'Hagan

Marketing Excellence and Market Development Strategy Capability Lead

Meghan Rivera

Meghan Rivera

VP, Global Commercial Strategy Lead

Buddy Scalera

Buddy Scalera

Associate Director, Omnichannel Operations & Content Governance

Simon Smith

Simon Smith

Executive Vice President, Generative AI

Josie Waters

Josie Waters

Senior Director, Marketing

Michele Chase Kashap

Michele Chase Kashap

VP, Global Commercial Operations

Pete Choo

Pete Choo

Partner, Commercial & Service Excellence

THE PROGRAM

Two days. Twenty sessions and counting.

Every session is built around a decision you are making this year.

Foundations and Readiness

Three Sessions

Building the Data Foundation Agents Run On to Prevent Scaling a Capability Your Infrastructure Cannot Support

  • Determine where commercial data actually lives, who controls it, and what reclaiming it takes
  • Recognize the failure pattern where commercial AI breaks on the data layer, not the model

Assessing Organizational Readiness for Agentic AI and Industry Benchmarking

  • Place your organization on the readiness curve using a framework you can carry back to leadership
  • Select use cases that survive a full scaling cycle while the models change underneath them

Reclaiming Commercial Data From Your Agencies to Own the Context Every Agent Depends On

  • Establish what your agencies hold and what bringing it back in house actually takes
  • Rebuild the ownership model so the context an agent needs is yours to govern

The Commercial Operating Model

Six Sessions

Driving Agentic Transformation From the Top to Rewire Commercial Operations

  • Establish the executive mandate that moves agentic AI from departmental pilot to enterprise strategy
  • Weigh what building rather than buying genuinely costs in people, time and political capital

Structuring AI Partnerships Between Pharma and Technology Providers to Ship Something Real Instead of Another Pilot

  • Set the contracting, data and intellectual property terms that determine whether the work scales
  • Identify the partnership failure patterns worth designing out before signature

Restructuring the Commercial Team for Agentic Work to Drive Adoption Instead of Building Systems Nobody Uses

  • Identify the skills marketers and field teams need, and how leaders are closing the gaps
  • Execute the change management that converts a working system into a used one

Standing Up a Commercial AI Function to Give the Work an Owner Instead of a Committee

  • Define what the function owns, how it was staffed, and where it sits
  • Settle what a center of excellence owns versus a brand team

Embedding Agentic AI Into CRM and Field Business Intelligence to Change What the Field Organization Can Do

  • Trace the internal systems work that changed field capability, from first pilot to production
  • Navigate the legal and compliance path for a field-facing capability

Running an Innovation Lab in the Age of AI: Tinkering, Talent and Taste

  • Structure a lab that produces commercial capability rather than demonstrations
  • Judge which experiments deserve to graduate, and retire the ones that do not

Customer and Patient Engagement

Six Sessions

Orchestrating Next-Best-Action Across Marketing, Access and Patient Services Without Adding Noise

  • Hand action selection to an agent across functions that never shared a plan
  • Show what the customer experienced on the other end

Reaching Prescribers at the Point of Decision With Agentic Intelligence

  • Locate where prescribers now form clinical views, and how fast that keeps moving
  • Redesign engagement around decision points instead of a channel calendar

Optimizing for Generative Engines to Ensure Your Brand Gets Cited When an AI Answers the Question

  • Rebuild owned channels for agents and bots, already the majority of web traffic
  • Prepare for the point where AI search overtakes traditional search

Accelerating Patient Identification and Treatment Initiation in Rare Disease by Connecting Fragmented Signals

  • Join diagnosis, referral and engagement data into one next action
  • Shorten the distance between a diagnosed patient and a treated one

Scaling Creative Production to Meet Channel Demand Your Content Supply Chain Was Never Built For

  • Structure modular content so assets get assembled rather than recreated
  • Compress the distance between a brief and an approved asset

Automating HCP Media Buying and Optimization to Put Budget Behind the Physicians Who Actually Change Prescribing

  • Target at the individual physician level while holding privacy and compliance constraints
  • Measure influence on prescribing behavior rather than impressions and clicks

Governance, Compliance and Proof

Five Sessions

Governing Multi-Agent Systems Across Functions and Geographies to Maintain Oversight Without Slowing Execution

  • Stand up the register of what every agent in the estate is permitted to do
  • Locate approval authority the moment an agent acts without a human in the loop

Clearing Agentic Content Through Medical, Legal and Regulatory Review to Cut Cycle Time Without Adding Risk

  • Define where agentic AI realistically fits the promotional review process, from first draft to final approval
  • Prepare the documentation reviewers request when a system generated the asset

Deploying an Agent Into a Live Launch to Compress the First Eighteen Months

  • Apply agentic capability where the budget and the pressure both sit
  • Report what the work shipped and what it returned

Measuring Return on Agentic Investment to Defend Your Budget and Stop the Programs That Are Not Working

  • Build measurement frameworks tied to commercial performance rather than activity volume
  • Present the case that gets a program funded, and the evidence that gets one stopped

Reading the Agentic Frontier From Outside Pharma

  • Show where agent capability actually stands outside a regulated industry
  • Separate the shifts that reach pharma commercial from the ones that will not

Session descriptions and faculty assignments are being finalized now. Most of our speakers are pharmaceutical executives, and internal approval takes time, so the program fills in steadily between now and November.

THE FACULTY

Hear from the leaders building with agentic AI in pharma.

We are assembling life sciences commercial leaders who are actively working with agentic AI today. Practitioners with hands-on experience to share.

Speakers are confirmed and announced on a rolling basis as each clears their own internal review. Full Program Agenda Release is Coming Soon.

WHY ATTEND

Top reasons to attend this event.

01

See what is actually working.

Real case studies from commercial teams already running agentic AI, including what has not worked. You leave with patterns you can apply.

02

Face time with your peers.

Senior commercial leaders from the top pharma companies, together for two days. The candid peer conversation this industry rarely gets when something is moving this fast.

03

Build the foundation before you scale.

The data, governance, and operating-model decisions that determine whether agentic AI actually delivers. Twenty sessions and counting, built around the calls you are making this year.

04

Be early to the playbook.

This is where the commercial playbook for agentic AI gets written: what MLR and compliance are actually approving, how leaders ship inside a regulated environment without slowing down, and where the category goes next.

05

Meet the tools and partners driving the change.

The technology vendors and solution providers building agentic AI for pharma are here. See what is real, pressure-test the platforms, and connect directly with the partners driving and leading the change, alongside the commercial teams deploying them.

OUR PARTNERS
Founding Partner Klick Health, Founding Partner of the Agentic Pharma Summit
Founding Partner Doceree, Founding Partner of the Agentic Pharma Summit
Founding Partner PwC, Founding Partner of the Agentic Pharma Summit
Partner The Rx Assistant, Partner of the Agentic Pharma Summit
Supporting Partner OpenEvidence, Supporting Partner of the Agentic Pharma Summit
THE VENUE

Convene at CityView, Philadelphia.

The Agentic Pharma Summit takes place at Convene at CityView, a premier meeting and event space in the heart of Center City Philadelphia. Purpose-built for focused, high-quality gatherings with best-in-class hospitality and technology.

30 South 17th Street, Philadelphia, PA 19103

View the Venue
ORGANIZER & HOST
Bryon Main, CEO of Momentum Events
Bryon Main
CEO
Momentum Events

Bryon Main has spent 25 years building the events where pharma commercial leaders learn from each other and build relationships that last. Digital Pharma, ePharma Summit, Pharmaceutical Marketing Congress, Pharmaceutical PR & Communications Summit. Events that defined the time and hosted thousands of attendees.

He leads Momentum Events, a B2B conference company specializing in events for life sciences executives. Momentum produces 15+ events per year across regulated industries, built on decades of deep relationships with the industry we serve, to ensure the right conversations happen at our events.

Agentic Pharma Summit is the next chapter.

SPONSORSHIP

Face time with the commercial leaders driving agentic AI within their organizations.

Senior pharma and biotech commercial leaders, two days, focused conversation about agentic AI. If your platform, product, or service helps this audience adopt, scale, or govern agentic AI, this summit is one of the most direct ways to reach them.

A focused set of ways to partner, from mainstage stage time to exhibit and networking, content, hosted experiences, and team access. Bryon personally manages every sponsor relationship and tailors the package to your goals.

Explore Partnership Options Schedule a Call
STAY IN THE LOOP

Join the interest list.

The founding rate is open: $1,795 for the first 25 seats, through August 15, 2026, whichever comes first. Register now, or join the list below and we'll only email when there's something worth sharing.

By joining, you agree to receive Agentic Pharma Summit updates from Momentum Events. Unsubscribe any time.

You're on the list. Watch your inbox for faculty announcements and program drops.

Agentic Pharma Summit